Clinical Trial Update: An Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Participants With Euvolemic or Hypervolemic Hyponatremia [Phase 3]

View source ↗

Summary

Phase 3 extension trial evaluating long-term safety in children and adolescents with euvolemic or hypervolemic hyponatremia; the study status is terminated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Hyponatremia | Phase 3 | Status: TERMINATED | Results posted: 2020-04-17